Akèy › Maladi fwa › Texas
Etid klinik pou Maladi fwa nan Texas
14 etid pou Maladi fwa ap chèche patisipan nan sit nan Texas.
Vil nan Texas
- Houston10 etid
- San Antonio6 etid
- Dallas5 etid
- Austin4 etid
- Fort Worth3 etid
- Brownsville3 etid
- Round Rock3 etid
- Carrollton3 etid
Tèks ofisyèl etid la (Anglè)
Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions
- Texas Liver Institute, San Antonio
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Sep 24, 2026 · NCT07654283A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
- Pinnacle Clinical Research, Austin
- Bellaire Clinical Research, Bellaire
- South Texas Research Institute (STRI) - Brownsville, Brownsville
- ak 14 plis
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 9, 2026 · NCT07288138A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Amarillo
- 89bio Clinical Study Site, Austin
- 89bio Clinical Study Site, Austin
- ak 21 plis
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Sep 3, 2026 · NCT06419374A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Amarillo
- 89bio Clinical Study Site, Austin
- 89bio Clinical Study Site, Austin
- ak 30 plis
Ap rekriteFaz 3
Laj 18 a 80 · Tout sèks · Mizajou Sep 3, 2026 · NCT06318169Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention
- MD Anderson Cancer Center, Houston
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT07010315Primary Sclerosing Cholangitis in Children
- Texas Children's Hospital (Baylor College of Medicine), Houston
Ap rekriteEtid obsèvasyon
Laj 2 a 25 · Tout sèks · Mizajou Jul 14, 2026 · NCT04181138Veteran-Centered Care for Advanced Liver Disease (Vet-CALD)
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Jun 25, 2026 · NCT06068491A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
- Clinical Trial Site, Dallas
- Clinical Trial Site, Houston
- Clinical Trial Site, San Antonio
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jun 17, 2026 · NCT06600321A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment
- Texas Liver Institute - American Research Corporation, San Antonio
- Pinnacle Clinical Research, San Antonio
Ap rekriteFaz 1
Laj 18 a 80 · Tout sèks · Mizajou Jun 16, 2026 · NCT07559474A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- St. David's South Austin Medical Center, Austin
- UT Southwestern Medical Center, Dallas
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Dec 15, 2025 · NCT06619561Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
- Baylor College of Medicine (Scott & White), Dallas
- Michael E DeBakey VA Medical Center, Houston
- Baylor St. Luke's Medical Centre, Houston
Ap rekriteEtid obsèvasyon
Laj 18 a 80 · Tout sèks · Mizajou Oct 20, 2025 · NCT04613921Safety and Efficacy of Atorvastatin v. Placebo on HCC Risk
- University of Texas Southwestern Medical Center, Dallas
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2025 · NCT05028829Allogenic Hepatocyte Transplantation Into Periduodenal Lymph Nodes
- Houston Methodist Hospital, Houston
Ap rekriteFaz 2
Laj 18 a 70 · Tout sèks · Mizajou Aug 8, 2025 · NCT04496479Hepatic Histopathology in Urea Cycle Disorders
- Baylor College of Medicine, Houston
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jul 20, 2025 · NCT04908319Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.